Age-Related Phenotype Enhancement Studies in naturally aged mice (24-month-old mice, which is equivalent to approximately 70 human years) showed remarkable results
[13] [3] It's important to note that as of 2024, tirzepatide does not have an FDA-approved cardiovascular risk-reduction indication, and dedicated cardiovascular outcomes trials are still ongoing
Neither medication is currently available in Canada through traditional channels, though Mazdutide has already received regulatory approval in China and sits closer to global market availability
Elevated intracellular calcium levels trigger downstream signalling molecules like Ca2+/calmodulin-dependent protein kinase II (CAMK II), protein kinase C (PKC), mitogen-activated protein kinases (MAPK), and protein phosphatases (PPs)
423 The research further demonstrated that this anti-inflammatory effect was not mediated by GLP-1R in the blood or endothelial cells but required the GLP-1R in the CNS